BEEP Follow Up: Evaluation of Repeatability of Lamotrigine Pharmacokinetics in Epileptic Patients
Status:
Completed
Trial end date:
2016-04-06
Target enrollment:
Participant gender:
Summary
The prior BEEP study involved patients being switched between brand and generic in a very
structured manner. Other secondary comparisons were also made (i.e. any differences in
adverse effects and seizure control). Some subjects were more disparate than other, in terms
of generic being similar to brand. In this follow up study, BEEP subjects that showed
disparate results will be tested again to assess reproducibility of disparate results.
Phase:
Phase 4
Details
Lead Sponsor:
University of Maryland University of Maryland, Baltimore